✦ LIBER ✦

Preservation and redirection of HPV16E7-specific T cell receptors for immunotherapy of cervical cancer

✍ Scribed by Kirsten B.J. Scholten; Marco W.J. Schreurs; Janneke J. Ruizendaal; Esther W.M. Kueter; Duco Kramer; Sharon Veenbergen; Chris J.L.M. Meijer; Erik Hooijberg

Book ID: 116366279
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 577 KB
Volume: 114
Category: Article
ISSN: 1090-2341
DOI: 10.1016/j.clim.2004.11.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Human Papillomavirus Type 16 (HPV16) E6/

Human Papillomavirus Type 16 (HPV16) E6/E7-Specific Cytotoxic T Lymphocytes (CTLs) for Immunotherapy of HPV-Associated Malignancies

✍ C.A. Ramos; N. Narala; A.M. Leen; U. Gerdemann; M.L. Anderson; E.M. Sturgis; B. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Generation of Tumor-Specific Cytotoxic T

Generation of Tumor-Specific Cytotoxic T Lymphocytes by Stimulation with HPV Type 16 E7 Peptide-Pulsed Dendritic Cells: An Approach to Immunotherapy of Cervical Cancer

✍ Wolfgang M.J. Schoell; Ramin Mirhashemi; Bai Liu; Mike F. Janicek; Eckhard R. Po 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 208 KB

Rapid enrichment of human papillomavirus

Rapid enrichment of human papillomavirus (HPV)-specific polyclonal T cell populations for adoptive immunotherapy of cervical cancer

✍ Annemieke de Jong; Jeanette M. van der Hulst; Gemma G. Kenter; Jan Wouter Drijfh 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 196 KB

## Abstract The majority of cervical cancers are caused by human papillomavirus type 16 (HPV16). Cervical cancer is associated with an ineffective host immune response against the HPV16 oncoproteins, characterized by the lack of the strong E6‐specific T‐helper type 1 (Th1) immunity that is generall

New highly potent and specific E6 and E7

New highly potent and specific E6 and E7 siRNAs for treatment of HPV16 positive cervical cancer

✍ Yamato, K; Yamada, T; Kizaki, M; Ui-Tei, K; Natori, Y; Fujino, M; Nishihara, T; 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 423 KB

Dendritic cell-based tumor vaccine for c

Dendritic cell-based tumor vaccine for cervical cancer I: in vitro stimulation with recombinant protein-pulsed dendritic cells induces specific T cells to HPV16 E7 or HPV18 E7

✍ Marion Nonn; Manuela Schinz; Klaus Zumbach; Michael Pawlita; Achim Schneider; Ma 📂 Article 📅 2003 🏛 Springer-Verlag 🌐 English ⚖ 348 KB

Highly potent and specific siRNAs agains

Highly potent and specific siRNAs against E6 or E7 genes of HPV16- or HPV18-infected cervical cancers

✍ Chang, J T-C; Kuo, T-F; Chen, Y-J; Chiu, C-C; Lu, Y-C; Li, H-F; Shen, C-R; Cheng 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 1019 KB